Abstract
The human class I alleles HLA-A11 and HLA-A3 have a well-documented history of serological cross-reactivity. This cross-reactivity suggests that they are closely related, a suggestion which is supported by the fact that the HLA-A11 and HLA-A3 genes are distinguished from all other A-locus genes by a restriction fragment length polymorphism observed in Bam HI digests. To examine the extent of sequence homology between HLA-A11 and HLA-A3, we have cloned the HLA-A11 gene and sequenced the coding regions (exons). The results reveal that HLA-A11 and HLA-A3 display the highest degree of homology reported for any pair of serologically defined class I alleles. Only nine base differences resulting in six amino acid differences were observed in exons 2–8. One of the amino acid substitutions is in the α1 domain and the other five are in the α2 domain. Comparison of this sequence with that of other human class I molecules implicates Gln62 as a critical residue involved in HLA-A11 – HLA-A3 serological cross-reactivity. In addition, the amino acid sequence allowed us to successfully predict cross-reactive recognition of HLA-A11 by cytotoxic T lymphocytes specific for a rare subtype of HLA-A3, HLA-A3.2. This result provides further support for the importance of the α2 domain residues 152 and 156 in forming determinants on class I molecules that are recognized by cytotoxic T lymphocytes.
Similar content being viewed by others
Abbreviations
- CTL:
-
cytotoxic T lymphocyte
- PBL:
-
peripheral blood lymphocyte
- PHA:
-
phytohemagglutinin
References
Aparicio, P., Vega, M., and López de Castro, J. A.: One allogeneic cytolytic T lymphocyte clone distinguishes three different HLA-1327 subtypes: Identification of amino acid residues influencing the specificity and avidity of recognition. J. Immunol. 135: 3074–3081, 1985
Biddison, W. E., Ward, F. E., Shearer, G. M., and Shaw, S.: The self determinants recognized by human virus-immune T cells can be distinguished from the serologically defined HLA antigens. J. Immunol. 124: 548–552, 1980
Biddison, W. E., Sharrow, S. O., and Shearer, G. M.: T cell subpopulations required for the human cytotoxic T lymphocyte response to influenza: Evidence for T cell help. J. Immunol. 127: 487–491, 1981
Biggin, M. D., Gibson, T. J., and Hong, G. F.: Buffer gradient gels and 35S label as an aid to rapid DNA sequence determinations. Proc. Natl. Acad. Sci. U.S.A. 80: 3963–3965, 1983
Biro, P. A., Pan, J., Sood, A. K., Kole, R., Reddy, V. B., and Weissman, S. M.: The human major histocompatibility complex. Cold Spring Harbor Symp. Quant. Biol. 47: 1079–1086, 1983
Brodsky, F. M., Parham, P., Barnstable, C. J., Crumpton, M. J., and Bodmer, W. F.: Monoclonal antibodies for analysis of the HLA system. Immunol. Rev. 47: 3–61, 1979
Choppin, J., Metzger, J. J., Bouillot, M., Briand, J. P., Connan, F., van Regenmortel, M. H. V., and Levy, J. P.: Recognition of HLA class I molecules by antisera directed to synthetic peptides corresponding to different regions on the HLA-B7 heavy chain. J. Immunol. 136: 1738–1744, 1986
Cowan, E. P., Coligan, J. E., and Biddison, W. E.: Human cytotoxic T lymphocyte recognition of an HLA-A3 gene product expressed on routine L cells: The only human gene product required on the target cells for lysis is the class I heavy chain. Proc. Natl. Acad. Sci. U. S. A. 82: 4490–4494, 1985a
Cowan, E. P., Jordan, B. R., and Coligan, J. E.: Molecular cloning and DNA sequence analysis of genes encoding cytotoxic T lymphocyte-defined HLA-A3 subtypes: The E1 subtype. J. Immunol. 135: 2835–2841, 1985b
Dorf, M. E., Eguro, S. Y., Dawson, J. R., Rauckman, E. J., and Amos, D. B.: Cross-reactions of HL-A antibodies. II. Continuous pH gradient elution. J. Immunol. 109: 681–685, 1972
Evans, G. E., Margulies, D. M., Shykind, B., Seidman, J. G., and Ozato, K.: Mapping polymorphic determinants on hybrid mouse transplantation antigens. Nature 300: 755–757, 1982
Ezquerra, A., Bragado, R., Vega, M. A., Strominger, J. L., Woody, J. A., and López de Castro, J. A.: Primary structure of papainsolubilized human histocompatibility antigen HLA-B27. Biochemistry 24: 1733–1741, 1985
Ezquerra, A., Doménech, N., van der Poel, J. J., and López de Castro, J. A.: HLA Class I Functional Sites: Structure of the HLA-A2. 4 Subtype Molecules. Sixth International Congress of Immunology, Abstract 2.31.4, 1986a
Ezquerra, A., Domenéch, N., van der Poel, J., Strominger, J. L., Vega, M. A., and López de Castro, J. A.: Molecular analysis of an HLA-A2 functional variant, CLA, defined by cytotoxic T lymphocytes. J. Immunol. 137: 1642–1649, 1986b
Fauchet, R., Bodmer, J. G., Kennedy, L. J., Mazzilli, M. C., Müller, C., Raffoux, C., and Richiardi, P.: HLA-A, B, C monoclonal antibodies. In E. D. Albert, M. P. Baur, and W. R. Mayr (eds.): Histocompatibility Testing 1984, pp. 211–217, Springer-Verlag, Berlin, 1984
Feinberg, A. P. and Vogelstein, B.: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132: 6–13, 1983
Ferrier, P., Fontecilla-Camps, J. C., Bucchini, D., Caillol, D. H., Jordan, B. R., and Lemonnier, F. A.: Altered structure of HLA class I heavy chains associated with mouse beta-2 microglobulin. Immunogenetics 21: 321–331, 1985
Foung, S. K. H., Taidi, B., Ness, D., and Grumet, F. C.: A monoclonal antibody against HLA-A11 and A24. Hum. Immunol. 15: 316–319, 1986
Frischauf, A.-M., Lehrach, H., Poustka, P., and Murray, N.: Lambda replacement vectors carrying polylinker sequences. J. Mol. Biol. 170: 827–842, 1983
Hämmerling, G. J., Rusch, E., Tada, N., Kimura, S., and Hämmerling, U.: Localization of allodeterminants on H-2Kb antigens determined with monoclonal antibodies and H-2 mutant mice. Proc. Natl. Acad. Sci. U.S.A. 79: 4737–4741, 1982
Holmes, N. and Parham, P.: Exon shuffling in vivo can generate novel HLA class I molecules. EMBO J. 4: 2849–2854, 1985
Kimball, E. S. and Coligan, J. E.: Structure and function of class I major histocompatibility antigens. Contemp. Top. Mol. Immunol. 9: 1–162, 1983
Kissmeyer-Nielsen, F. and Walford, R. L.: Antigen report: HLA-A3. In E. D. Albert, M. P. Baur, and W. R. Mayr (eds.): Histocompatibility Testing 1984, pp. 119, Springer-Verlag, Berlin, 1984a
Kissmeyer-Nielsen, F. and Walford, R. L.: Antigen report: HLA-A11. In E. D. Albert, M. P. Bunt, and W. R. Mayr (eds.): Histocompatibility Testing 1984, pp. 120, Springer-Verlag, Berlin, 1984b
Klein, J., Hauptfeld, M., and Hauptfeld, V.: Serological distinction of mutants B6.C-H(zl) and B6.M505 from strain C57BL/6. J. Exp. Med. 140: 1127–1132, 1974
Koller, B. H. and Orr, H. T.: Cloning and complete sequence of an HLAA2 gene: Analysis of two HLA-A alleles at the nucleotide level. J. Immunol. 134: 2727–2733, 1985
Koller, B. H., Sidwell, B., DeMars, R., and Orr, H. T.: Isolation of HLA locus-specific probes from the 3′-untranslated region. Proc. Natl. Acad. Sci. U.S.A. 81: 5175–5178, 1984
Koller, B. H., Ward, F. E., DeMars, R., and Orr, H. T.: Comparison of multiple HLA-A alleles at the DNA level by using Southern blotting and HLA-A-specific probes. J. Immunol. 135: 4229–4234, 1985
Kottmann, A. H., Seemann, G. H. A., Guessow, H. D., and Roos, M. H.: DNA sequence of the coding region of the HLA-B44 gene. Immunogenetics 23: 396–400, 1986
Krangel, M. S., Taketani, S., Biddison, W. E., Strong, D. M., and Strominger, J. L.: Comparative structural analysis of HLA-A2 antigens distinguishable by cytotoxic T lymphocytes: Variants M7 and DR1. Biochemistry 21: 6313–6321, 1982
Krangel, M. S., Biddison, W. E., and Strominger, J. L.: Comparative structural analysis of HLA-A2 antigens distinguishable by cytotoxic T lymphocytes. II. Variant DK1: Evidence for a discrete CTL recognition region. J. Immunol. 130: 1856–1862, 1983
Lew, A. M., Lillehoj, E. P., Cowan, E. P., Maloy, W. L., van Schravendijk, M. R., and Coligan, J. E.: Class I genes and molecules: An update. Immunology 57: 3–18, 1986
López de Castro, J. A., Strominger, J. L., Strong, D. M., and Orr, H. T.: Structure of cross-reactive human histocompatibility antigens HLA-A28 and HLA-A2: Possible implications for the generation of the HLA polymorphism. Proc. Natl. Acad. Sci. U.S.A. 79: 3813–3817, 1982
López de Castro, J. A., Bragado, R., Strong, D. M., and Strominger, J. L.: Primary structure of papain-solubilized human histocompatibility antigen HLA-B40 (-Bw60). An outline of alloantigenic determinants. Biochemistry 22: 3961–3969, 1983
López de Castro, J. A., Barbosa, J. A., Krangel, M. S., Biro, P. A., and Strominger, J. L.: Structural analysis of the functional sites of class I HLA antigens. Immunol. Rev. 85: 149–168, 1985
Maryanski, J. L., Moretta, A., Jordan, B. R., DePlaen, E., Van Pel, A., Boon, T., and Cerottini, J. C.: Human T cell recognition of cloned HLA class I gene products expressed on DNA transfectants of mouse mastocytoma P815. Eur. J. Immunol. 15: 1111–1117, 1985
Mittal, K. K. and Terasaki, P. I.: Serological cross-reactivity in the HLA system. Tissue Antigens 4: 146–156, 1974
Nathenson, S. G., Geliebter, J., Pfaffenbach, G. M., and Zeff, R. A.: Murine major histocompatibility complex class I mutants: Molecular analysis and structure-function implications. Annu. Rev. Immunol. 4: 471–502, 1986
N'Guyen, C., Sodoyer, R., Trucy, J., Strachan, T., and Jordan, B. R.: The HLA-Aw24 gene: Sequence, surroundings and comparison with the HLA-A2 and HLA-A3 genes. Immunogenetics 21: 479–489, 1985
Ozato, K., Mayer, N. M., and Sachs, D. H.: Monoclonal antibodies to mouse major histocompatibility complex antigens. IV. A series of hybridoma clones producing anti-H-2Dd antibodies and an examination of expression of H-2d antigens on the surface of these cells. Transplantation 34: 113–120, 1982
Paul, P., Lepage, V., Sayagh, B., Metzger, J.-J., Pla, M., Boumsell, L., Douay, C., Cohen, D., Colombani, J., Dausset, J., and Degos, L.: Serological expression after sequential double transfection withpuri fied HLA-A11 gene of mouse fibroblasts carrying human beta-2 microglobulin. Immunogenetics 22: 1–8, 1985
Raffoux, C. and Streiff, F.: Joint report—A11. In P. I. Terasaki (ed.): Histocompatibility Testing 1984, p. 301, UCLA, Los Angeles, California, 1980
Robinson, M. A., Long, E. O., Johnson, A. H., Hartzman, R. J., Mach, B., and Kindt, T. J.: Recombination within the HLA-D region: Correlation of molecular genotyping with functional data. J. Exp. Med. 160: 222–238, 1984
Rojo, S., López de Castro, J. A., Aparicio, P., van Seventer, G., and Bragado, R.: HLA-B27 anfigenicity: Antibodies against the chemically synthesized 63–84 peptide from HLA-B27.1 display alloantigenic specificity and discriminates among HLA-B27 subtypes. J. Immunol. 137: 904–910, 1986
Russo, C., Ng, A. K., Pellegrino, M. A., and Ferrone, S.: The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells. Immunogenetics 18: 23–35, 1983
Sanger, F., Nicklen, S., and Coulson, A. R.: DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U.S.A. 74: 5463–5465, 1977
Sodoyer, R., Damotte, M., Delovitch, T. L., Trucy, J., Jordan, B. R., and Strachan, T.: Complete nucleotide sequence of a gene encoding a functional human class I histocompatibility antigen (HLA-Cw3). EMBO J. 3: 879–885, 1984
Sodoyer, R., Kahn-Perles, B., Strachan, T., Sire, J., Santoni, M.-J., Layet, C., Ferrier, P., Jordan, B. R., and Lemonnier, F. A.: Transfection of murine LMTK− cells with purified HLA class I genes. VII. Association of allele- and locus-specific serological reactivities with respectively the first and second domains of the HLA-B7 molecule. Immunogenetics 23: 246–251, 1986
Southern, E. M.: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98: 503–517, 1975
Strachan, T., Sodoyer, R., Damotte, M., and Jordan, B. R.: Complete nucleotide sequence of a functional class I HLA gene, HLA-A3: Implications for the evolution of class I genes. EMBO J. 3: 887–894, 1984
Taketani, S., Krangel, M. S., Spits, H., de Vries, J., and Strominger, J. L.: Structural analysis of an HLA-B7 antigen variant detected by cytotoxic T lymphocytes. J. Immunol. 133: 816–821, 1984
Van Pel, A., DePlaen, E., and Boon, T.: Selection of a highly transfectable variant from mouse mastocytoma P815. Somatic Cell Mol. Genet. 11: 467–475, 1985
van Schravendijk, M. R., Biddison, W. E., Berger, A. E., and Coligan, J. E.: Comparative structural analysis of HLA-A3 antigens distinguishable bycytotoxic T-lymphocytes: Variant E1. J. Immunol. 134: 410–416, 1985
Vega, M. A., Bragado, R., Ezquerra, A., and López de Castro, J. A.: Variability and conformation of HLA class I antigens: A predictive approach to the spatial arrangement of polymorphic regions. Biochemistry 23: 823–831, 1984
Vega, M. A., Ezquerra, A., Rojo, S., Aparicio, P., Bragado, R., and López de Castro, J. A.: Structural analysis of an HLA-B27 functional variant: Identification of residues that contribute to the specificity of recognition by cytolytic T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 82: 7394–7398, 1985a
Vega, M. A., Wallace, L., Rojo, S., Bragado, R., Aparicio, P., and López de Castro, J. A.: Delineation of functional sites in HLA-B27 antigens. Molecular analysis of HLA-B27 variant Wewak I defined by cytolytic T lymphocytes. J. Immunol. 135: 3323–3332, 1985b
Vieira, J. and Messing, J.: The pUC plasmids, an M 13 mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene 19: 259–268, 1982
Walker, L. E., Ketler, T. A., Houghten, R. A., Schulz, G., Chersi, A., and Reisfeld, R. A.: Human major histocompatibility complex class I antigens: Residues 61–83 of the HLA-B7 heavy chain specify an alloreactive site. Proc. Natl. Acad. Sci. U.S.A. 82: 539–542, 1985
Ways, J. P., Coppin, H. L., and Parharn, P.: The complete primary structure of HLA-Bw58. J. Biol. Chem. 260: 11924–11933, 1985
Ways, J. P., Rothbard, J. B., and Parham, P.: Amino acid residues 56 to 69 of HLA-A2 specify an antigenic determinant shared by HLA-A2 and HLA-B17. J. Immunol. 137: 217–222, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cowan, E.P., Jelachich, M.L., Biddison, W.E. et al. DNA sequence of HLA-A11: Remarkable homology with HLA-A3 allows identification of residues involved in epitopes recognized by antibodies and T cells. Immunogenetics 25, 241–250 (1987). https://doi.org/10.1007/BF00404694
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00404694